Your browser doesn't support javascript.
loading
Kratom (Mitragyna speciosa): A Case Review of Use Before and During Pregnancy.
Faucher, Mary Ann; Morillos, Stephanie; Cordova, Polly; McNeil-Santiel, Jessica; Onisko, Nancy; Adhikari, Emily H; Nelson, David B.
Afiliación
  • Faucher MA; Women & Infants Specialty Health, Parkland Health, Dallas, Texas.
  • Morillos S; Women & Infants Specialty Health, Parkland Health, Dallas, Texas.
  • Cordova P; Women & Infants Specialty Health, Parkland Health, Dallas, Texas.
  • McNeil-Santiel J; Women & Infants Specialty Health, Parkland Health, Dallas, Texas.
  • Onisko N; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Adhikari EH; Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Nelson DB; Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
J Midwifery Womens Health ; 69(1): 144-149, 2024.
Article en En | MEDLINE | ID: mdl-37679866
ABSTRACT
Kratom (Mitragyna speciosa) is a plant-based substance with psychoactive properties similar to opioids but is not currently classified as an opioid. One of its more prevalent uses is to treat opioid dependency and withdrawal symptoms. Opioid use disorder is a leading cause of pregnancy-associated maternal mortality, and pregnant women may be using kratom as a substitute or alternative to opioids. Prevalence of kratom use is increasing rapidly, but scientific evidence specific to therapeutic and adverse effects is lacking overall, and the implications of its use in pregnancy and on the fetus-newborn are limited to a few case reports. Kratom is a legal substance by federal law, although some states have banned its use. The lack of regulation is concerning. Significant illness and associated deaths have been reported with kratom use. Lack of disclosure by people using kratom and limited laboratory testing options are major challenges for health care providers and public health.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Abstinencia a Sustancias / Mitragyna / Trastornos Relacionados con Opioides Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: J Midwifery Womens Health Asunto de la revista: ENFERMAGEM / OBSTETRICIA / SAUDE DA MULHER Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Abstinencia a Sustancias / Mitragyna / Trastornos Relacionados con Opioides Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: J Midwifery Womens Health Asunto de la revista: ENFERMAGEM / OBSTETRICIA / SAUDE DA MULHER Año: 2024 Tipo del documento: Article
...